Preview
Unable to display preview. Download preview PDF.
Références
Elit L, Chambers A, Fyles A et al. (2004) Systematic review of adjuvant care for women with Stage I ovarian carcinoma. Cancer 101(9): 1926–35
Hreshchyshyn MM, Park RC, Blessing JA et al. (1980) The role of adjuvant therapy in Stage I ovarian cancer. Am J Obstet Gynecol 138(2): 139–45
Dembo AJ, Van Dyk J, Japp B et al. (1979) Whole abdominal irradiation by a moving-strip technique for patients with ovarian cancer. Int J Radiat Oncol Biol Phys 5(11–12): 1933–42
Chiara S, Conte P, Franzone P et al. (1994) High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy. Am J Clin Oncol 17(1): 72–6
Gronroos M, Nieminen U, Kauppila A et al. (1984) A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation. Eur J Obstet Gynecol Reprod Biol 17(1): 33–42
Fuller DB, Sause WT, Plenk HP et al. (1987) Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma. J Clin Oncol 5(6): 897–905
MacGibbon A, Bucci J, MacLeod C et al. (1999) Whole abdominal radiotherapy following second-look laparotomy for ovarian carcinoma. Gynecol Oncol 75(1): 62–7
Debby A, Levy T, Hayat H et al. (2004) Whole-abdomen, single-dose consolidation radiotherapy in patients with pathologically confirmed complete remission of advanced ovarian epithelial carcinoma: a long-term survival analysis. Int J Gynecol Cancer 14(5): 794–8
Martinez A, Schray MF, Howes AE et al. (1985) Postoperative radiation therapy for epithelial ovarian cancer: the curative role based on a 24-year experience. J Clin Oncol 3(7): 901–11
Lambert HE, Rustin GJ, Gregory WM et al. (1993) A randomized trial comparing singleagent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group study. J Clin Oncol 11(3): 440–8
Sorbe B (2003) Consolidation treatment of advanced ovarian carcinoma with radiotherapy after induction chemotherapy. Int J Gynecol Cancer 13Suppl 2: 192–5
Bruzzone M, Repetto L, Chiara S et al. (1990) Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look. Gynecol Oncol 38(3): 392–5
Berlie J, Delouche G, Weber B et al. (1987) Four year survival of ovarian serous carcinoma (stage IIC, III, IV FIGO) treated by two four-drug chemotherapy: AVEC (ADR, VM26, CTX, CDDP) versus CHAP (CTX, HMM, ADR, CDDP) and for responders after the second-look, a maintenance treatment: total abdominal radiotherapy vs chemotherapy. A double randomized trial of the gynecological group of the french centers Berlie1987. Pro 4th European Conference on Clinical Oncology and Cancer Nursing (ECCO4), 784. Ref Type: Abstract
Lawton F, Luesley D, Blackledge G et al. (1990) A randomized trial comparing whole abdominal radiotherapy with chemotherapy following cisplatinum cytoreduction in epithelial ovarian cancer. West Midlands Ovarian Cancer Group Trial II. Clin Oncol (R Coll Radiol) 2(1): 4–9
Pickel H, Lahousen M, Petru E et al. (1999) Consolidation radiotherapy after carboplatinbased chemotherapy in radically operated advanced ovarian cancer. Gynecol Oncol 72(2): 215–9
Dembo AJ (1983) Radiation therapy in the management of ovarian cancer. Clin Obstet Gynaecol 10, 261–78
Delclos L, Smith J (1973) Tumors of the ovary. Text-book of radiotherapy 690–702
Fletcher G, Shukovsky L (1975) The interplay of radiocurability and tolerance in the irradiation of human cancers. J Radiol Electrol 56: 383–400
Eifel PJ, Gershenson DM, Delclos L et al. (1991) Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma. Int J Radiat Oncol Biol Phys 21(4): 1013–8
Randall ME, Barrett RJ, Spirtos NM et al. (1996) Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 34(1): 139–47
Young RC, Walton LA, Ellenberg SS, et al. (1990) Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med 322(15): 1021–7
Vergote I, De Vos L, Abeler V et al. (1992) Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of ovarian cancer. Cancer 69: 741–9
Klaasen D, Shelley W, Starreveld A et al. (1988) Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical trials Group Report. J Clin Oncol 6: 1254–63
Vergote I, Winderen M, De Vos L et al. (1993) Intraperitoneal radioactive phosphate in early ovarian carcinome: an analysis of complications. Cancer 71: 2250–60
Varia M, Rosenman J, Venkatraman S et al. (1988) Intraperitoneal chromic phosphate therapy after second-look laparotomy for ovarian cancer. Cancer 61(5): 919–27
Varia MA, Stehman FB, Bundy BN et al. (2003) Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group. J Clin Oncol 21(15): 2849–55
Rights and permissions
Copyright information
© 2006 Springer-Verlag France
About this chapter
Cite this chapter
Claude, L., Sunyach, MP. (2006). Radiothérapie de clôture. In: Les cancers ovariens. Abord clinique. Springer, Paris. https://doi.org/10.1007/2-287-30921-7_22
Download citation
DOI: https://doi.org/10.1007/2-287-30921-7_22
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-25168-9
Online ISBN: 978-2-287-30921-2